| 标题 |
A prospective, multicenter, randomized controlled trial to verify the safety and efficacy of a nano-membrane single riveted ventricular septal defect (VSD) occluder in clinical practice
一项验证纳米膜单铆接室间隔缺损(VSD)封堵器在临床实践中安全性和有效性的前瞻性、多中心、随机对照试验
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | INTERVENTION: Group A:nano membrane single riveted ventricular septal defect (VSD) occluder;Group B:ventricular septal defect (VSD) occluder; CONDITION: Ventricular septal defect PRIMARY OUTCOME: blocking success rate; SECONDARY OUTCOME: technique success rate; INCLUSION CRITERIA: 1. Aged 1 to 60 years old, weight more than 5 kg, male or non‐pregnant women; 2. Membranous ventricular septal defect with hemodynamic abnormalities or increased left ventricular diamete 3. The narrowest part of ventricular septal defect (VSD) 3mm to 12mm; 4. The upper margin of the ventricular septal defect is >=2mm from the right aortic valve and >=2mm from the tricuspid septal valve. There is no aortic right coronary valve detachment into the ventricular septal defect and aortic valve reflux; 5. Ultrasound at 9‐12 o'clock on the short‐axis five‐chamber view of the large vessel; 6. Understand the purpose of the trial, volunteer to participate in the trial and sign the "Informed Consent form". |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
黑糖珍珠
带头大哥
怕黑半仙
爱静静
春夏爱科研
muziyang
SciGPT
mhl11
科目三
瑞_
iNk
个性的紫菜
33
Kaiser
一枚研究僧
ppg123
Owen
小二郎
宜醉宜游宜睡
雨相所至
皖公网安备34019202002308
